Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elzbieta Waszczykowska

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 19, 2003
[Systemic sclerosis: symptomatic treatment]Bozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Kamila Skretkowicz
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 19, 2003
[Systemic sclerosis: drugs and new therapeutic methods]Kamila Skretkowicz, Elzbieta Waszczykowska, Bozena Dziankowska-Bartkowiak
Postepy Dermatologii I Alergologii|July 4, 2017
Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndromeKatarzyna Juczynska, Anna Wozniacka, Elzbieta Waszczykowska, et al.
Mediators of Inflammation|December 12, 2003
Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvementBozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Anna Zalewska, et al.
Mediators of Inflammation|February 21, 2006
The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformisAgnieszka Zebrowska, Joanna Narbutt, Anna Sysa-Jedrzejowska, et al.
Mediators of Inflammation|August 18, 2005
Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patientsBozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Anna Zalewska, et al.
Przeglad Lekarski|June 3, 2010
[Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]Bozena Dziankowska-Bartkowiak, Agnieszka Zebrowska, Małgorzata Wagrowska-Danielewicz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 23, 2002
Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: a preliminary studyBozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Maria Łuczyńska, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 6, 2006
Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoidJoanna Narbutt, Elzbieta Waszczykowska, Jolanta Lukamowicz, et al.
Postepy Dermatologii I Alergologii|November 27, 2013
Genetic polymorphisms of CYP2D6 oxidation in patients with autoimmune bullous diseasesMariola Rychlik-Sych, Małgorzata Baranska, Elzbieta Waszczykowska, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 19, 2003
[Systemic sclerosis: symptomatic treatment]Bozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Kamila Skretkowicz
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 19, 2003
[Systemic sclerosis: drugs and new therapeutic methods]Kamila Skretkowicz, Elzbieta Waszczykowska, Bozena Dziankowska-Bartkowiak
Postepy Dermatologii I Alergologii|July 4, 2017
Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndromeKatarzyna Juczynska, Anna Wozniacka, Elzbieta Waszczykowska, et al.
Mediators of Inflammation|December 12, 2003
Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvementBozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Anna Zalewska, et al.
Mediators of Inflammation|February 21, 2006
The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformisAgnieszka Zebrowska, Joanna Narbutt, Anna Sysa-Jedrzejowska, et al.
Mediators of Inflammation|August 18, 2005
Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patientsBozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Anna Zalewska, et al.
Przeglad Lekarski|June 3, 2010
[Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]Bozena Dziankowska-Bartkowiak, Agnieszka Zebrowska, Małgorzata Wagrowska-Danielewicz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 23, 2002
Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: a preliminary studyBozena Dziankowska-Bartkowiak, Elzbieta Waszczykowska, Maria Łuczyńska, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 6, 2006
Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoidJoanna Narbutt, Elzbieta Waszczykowska, Jolanta Lukamowicz, et al.
Postepy Dermatologii I Alergologii|November 27, 2013
Genetic polymorphisms of CYP2D6 oxidation in patients with autoimmune bullous diseasesMariola Rychlik-Sych, Małgorzata Baranska, Elzbieta Waszczykowska, et al.
Pageof 3